Data / Drug companies / Octapharma USA Inc
Octapharma USA Inc: 24 products in the FDA NDC directory, labeler code 68982
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Octapharma USA Inc (labeler code 68982) lists 24 products in the FDA National Drug Code Directory, covering 7 finished drugs by generic name. By type: 24 plasma derivatives. Its main marketing category is biologics (BLA). The newest product started marketing on June 23, 2025.
The request: Watch Octapharma USA Inc (FDA labeler code 68982): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 68982
- Products in commercial distribution
- 24
- Packages
- 48
- Finished drugs by generic name
- 7
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- May 21, 2004
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Biologics (BLA) | 24 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Plasma derivatives | 24 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Antihemophilic factor (recombinant) | 8 | 4 |
| Human plasma proteins | 4 | 1 |
| Albumin human | 3 | 3 |
| Fibrinogen (human) | 3 | 1 |
| Immune globulin | 2 | 2 |
| Immune globulin intravenous (human) | 1 | 3 |
| Immunoglobulin g | 1 | 2 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution | 11 | 45.8% |
| Kit | 9 | 37.5% |
| Powder, for solution | 4 | 16.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Human Blood Coagulation Factor | 4 |
| Human Immunoglobulin G | 4 |
| Human Serum Albumin | 3 |
| Anti-coagulant | 1 |
| Blood Coagulation Factor | 1 |
| Human Antihemophilic Factor | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Fibryga | 68982-350 | Powder, for solution | Biologics (BLA) | June 23, 2025 |
| Fibryga | 68982-349 | Powder, for solution | Biologics (BLA) | December 20, 2024 |
| Balfaxar | 68982-261 | Powder, for solution | Biologics (BLA) | November 30, 2023 |
| Nuwiq | 68982-153 | Kit | Biologics (BLA) | December 12, 2021 |
| Cutaquig | 68982-810 | Solution | Biologics (BLA) | May 3, 2019 |
| Panzyga | 68982-822 | Solution | Biologics (BLA) | November 12, 2018 |
| Fibryga | 68982-347 | Kit | Biologics (BLA) | October 16, 2017 |
| Nuwiq | 68982-151 | Kit | Biologics (BLA) | August 1, 2017 |
| Nuwiq | 68982-149 | Kit | Biologics (BLA) | August 1, 2017 |
| Nuwiq | 68982-147 | Kit | Biologics (BLA) | August 1, 2017 |
| Nuwiq | 68982-145 | Kit | Biologics (BLA) | January 1, 2016 |
| Nuwiq | 68982-143 | Kit | Biologics (BLA) | January 1, 2016 |
| Nuwiq | 68982-141 | Kit | Biologics (BLA) | January 1, 2016 |
| Nuwiq | 68982-139 | Kit | Biologics (BLA) | January 1, 2016 |
| Octaplas | 68982-955 | Solution | Biologics (BLA) | July 18, 2013 |
| Octaplas | 68982-954 | Solution | Biologics (BLA) | July 18, 2013 |
| Octaplas | 68982-953 | Solution | Biologics (BLA) | July 18, 2013 |
| Octaplas | 68982-952 | Solution | Biologics (BLA) | July 18, 2013 |
| Wilate - von Willebrand Factor/Coagulation Factor VIII Complex (Human) | 68982-182 | Powder, for solution | Biologics (BLA) | December 4, 2009 |
| Albumin (Human) | 68982-643 | Solution | Biologics (BLA) | October 17, 2006 |
| Albumin (Human) | 68982-633 | Solution | Biologics (BLA) | October 17, 2006 |
| Albumin (Human) | 68982-623 | Solution | Biologics (BLA) | October 17, 2006 |
| Octagam Immune Globulin (Human) | 68982-850 | Solution | Biologics (BLA) | May 21, 2004 |
| Octagam Immune Globulin (Human) | 68982-840 | Solution | Biologics (BLA) | May 21, 2004 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.